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Stellingen behorende bij dit proefschrift
HYMENOPTERA VENOM ALLERGY
Challenges in diagnosis and treatment
1. The reduced immunoreactivity against Ves v 5 in yellow jacket venom extract can be overcome by 
spiking with recombinant major allergen Ves v 5.
This thesis
2. The sensitivity of yellow jacket venom-sIgE in patients with indolent systemic mastocytosis can be 
improved by lowering the reference value to 0.17 kUA/L, while retaining good specificity.
This thesis
3. All patients with indolent systemic mastocytosis should undergo sensitization screening for yellow 
jacket venom.
This thesis
4. Therapeutic success of venom immunotherapy correlates with the duration of therapy, type of 
venom, and venom dose while it is negatively influenced by systemic adverse reactions during venom 
immunotherapy and adult-onset of cutaneous mastocytosis and/or a basal serum tryptase over 20 μg/L.
This thesis
5. In older overweight patients suspected of indolent systemic mastocytosis, methylimidazole acetic acid 
has a greater value for estimating the need of a bone marrow biopsy compared with tryptase.
This thesis
6. Initiation of yellow jacket venom immunotherapy with the maintenance dose might be safe, effective 
and pharmaco-economically advantageous in a selected group of patients.
This thesis
7. Patients are generally poor insect discriminators.
This thesis
8. One of the main blessings of the slow news season in the media is the perfect opportunity to recruit 
patients for sting challenges.
9. A lot of people think something is right, and so that thing becomes right.
Paulo Coelho
10. Alles ist einfacher, als man denken kann, zugleich verschränkter, als zu begreifen ist.
Johann Wolfgang von Goethe
Byrthe Vos, maart 2017
